These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8180816)

  • 21. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.
    Parain K; Murer MG; Yan Q; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
    Neuroreport; 1999 Feb; 10(3):557-61. PubMed ID: 10208589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase contrast radiography of Lewy bodies in Parkinson disease.
    Koh SB; Suh SI; Lee DH; Kim AR; Oh CH; Yoon JS; Weon BM; Seol SK; Pyun AR; Je JH; Hwu Y; Margaritondo G
    Neuroimage; 2006 Aug; 32(2):566-9. PubMed ID: 16766209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marinesco bodies and substantia nigra neuron density in Parkinson's disease.
    Abbott RD; Nelson JS; Ross GW; Uyehara-Lock JH; Tanner CM; Masaki KH; Launer LJ; White LR; Petrovitch H
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):621-630. PubMed ID: 28626918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 25. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA; Shank DL; Alzofon J; Dudley AW
    Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of somal Lewy bodies to neuronal death.
    Tompkins MM; Hill WD
    Brain Res; 1997 Nov; 775(1-2):24-9. PubMed ID: 9439824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
    Li JY; Englund E; Widner H; Rehncrona S; Björklund A; Lindvall O; Brundin P
    Mov Disord; 2010 Jun; 25(8):1091-6. PubMed ID: 20198645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centenary of Lewy bodies (1912-2012).
    Holdorff B; Rodrigues e Silva AM; Dodel R
    J Neural Transm (Vienna); 2013 Apr; 120(4):509-16. PubMed ID: 23456291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic schizophrenia and idiopathic Parkinson's disease.
    Lam RW
    Can J Psychiatry; 1993 Mar; 38(2):75-7. PubMed ID: 8096793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of Parkinson's disease.
    Mann DM; Yates PO
    Arch Neurol; 1982 Sep; 39(9):545-9. PubMed ID: 7115143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
    Hughes AJ; Daniel SE; Lees AJ
    Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):745-52. PubMed ID: 2841426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases.
    Mark MH; Sage JI; Dickson DW; Schwarz KO; Duvoisin RC
    Neurology; 1992 Jul; 42(7):1323-7. PubMed ID: 1620341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
    Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
    Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
    Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
    Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
    Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.